Kevin Sanders MD

Kevin Sanders Committed to the development of safe and effective treatments for individuals with neurodevelopmental disabilities. Currently serving as the lead of the late stage autism program at Roche in Basel, Switzerland. Before Roche he was an Associate Clinical Professor of Psychiatry and the Director of the Child and Adolescent Psychiatry Division at Vanderbilt University. He also served as the Director of the Child Psychiatry Consult Service at Vanderbilt Children’s Hospital, attending inpatient physician at the Vanderbilt Psychiatry Hospital, co-site PI of the Autism Treatment Network, Director of MEND research program and Medial Director of TRIAD at Vanderbilt Kennedy Center. He has had extensive experience in clinical research in Autism, including participation either as a principal investigator or sub-investigator in most trials for NMEs targeting ASD, including arbaclofen, mavoglurant, basimglurant, basmisanil (DS) and memantine. He is the site PI of federally sponsored metformin and oxytocin trials for ASD conducted at Vanderbilt. Kevin did his MD training at University of Tennessee College of Medicine, his residency in Psychiatry at University of North Carolina, Chapel Hill, and completed his Child and Adolescent Psychiatry fellowship at Duke University where he served as the chief fellow. He is board certified in General Psychiatry and Child and Adolescent Psychiatry.